# A Double-masked, Randomized, Placebo-controlled,Pilot Study of Diquafosol Tetrasodium in Subjects Following Photorefractive Keratectomy (PRK)

> **NCT01381731** · PHASE2 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 14 (actual)

## Conditions studied

- Photorefractive Keratectomy

## Interventions

- **DRUG:** diquafosol tetrasodium ophthalmic solution 2%
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01381731
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-04
- **Primary completion:** 2005-06
- **Final completion:** 2005-06
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2015-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01381731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01381731, "A Double-masked, Randomized, Placebo-controlled,Pilot Study of Diquafosol Tetrasodium in Subjects Following Photorefractive Keratectomy (PRK)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01381731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*